MDxHealth SA ADR (MDXH)

Currency in USD
3.580
-0.260(-6.77%)
Closed·
3.5800.000(0.00%)
·
MDXH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.5603.780
52 wk Range
1.3505.330
Key Statistics
Prev. Close
3.84
Open
3.78
Day's Range
3.56-3.78
52 wk Range
1.35-5.33
Volume
63.07K
Average Volume (3m)
193.62K
1-Year Change
82.6531%
Book Value / Share
-0.17
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDXH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.040
Upside
+96.65%
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

MDxHealth SA ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

MDxHealth ADR Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company’s testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient’s previously biopsied negative tissue; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient’s infection. It also offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration with the University of Oxford: the initiation of Genomic Prostate Score (GPS) testing in the landmark UK ProtecT trial (Prostate Testing for Cancer and Treatment). The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

MDxHealth SA ADR Earnings Call Summary for Q2/2025

  • Q2 2025 revenue up 20% to $26.6M; stock jumps 11.34% despite EPS miss of -$0.15 vs -$0.1167 forecast
  • First quarter of adjusted EBITDA profitability at $1.4M; gross margins improve to 66%
  • Projecting 30%+ revenue growth in 2026; ExoDx acquisition expected to add $20M+ in revenue
  • CEO highlights 50%+ CAGR; ExoDx to accelerate growth in prostate cancer diagnostics
  • Analysts maintain Strong Buy rating; price targets $4.20-$8.00 suggest significant upside potential
Last Updated: 14/08/2025, 18:26
Read Full Transcript

Compare MDXH to Peers and Sector

Metrics to compare
MDXH
Peers
Sector
Relationship
P/E Ratio
−5.6x−1.4x−0.6x
PEG Ratio
−0.10−0.100.00
Price/Book
−21.4x3.1x2.6x
Price / LTM Sales
1.7x103.5x3.4x
Upside (Analyst Target)
82.3%1,227.5%41.5%
Fair Value Upside
Unlock6.6%5.5%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.040
(+96.65% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Buy7.00+95.53%-Maintain23/12/2025
TD Cowen
Buy7.00+95.53%5.00Maintain13/11/2025
Lake Street Capital Markets
Buy9.00+151.40%7.00Maintain13/11/2025
BTIG
Buy7.00+95.53%6.00Maintain13/11/2025
Craig-Hallum
Buy8.00+123.46%-New Coverage17/07/2025

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
-0.16 / -0.11
Revenue / Forecast
27.40M / 28.12M
EPS Revisions
Last 90 days

People Also Watch

6.24
SGHT
-3.55%
32.410
NAMS
+2.40%
36.10
PLOW
-1.18%
26.00
CMPO
+3.50%
4.060
HLLY
-1.69%

FAQ

What Is the MDxHealth ADR (MDXH) Share Price Today?

The live MDxHealth ADR share price today is 3.580

What Stock Exchange Does MDxHealth ADR (MDXH) Trade On?

MDxHealth ADR is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for MDxHealth ADR?

The stock symbol (also called a 'ticker') for MDxHealth ADR is "MDXH."

What Is the Current MDxHealth ADR Market Cap?

As of today, MDxHealth ADR market capitalisation is 190.07M.

What Is MDxHealth ADR's (MDXH) Earnings Per Share (TTM)?

The MDxHealth ADR EPS is currently -0.64 (Trailing Twelve Months).

When Is the Next MDxHealth ADR Earnings Date?

MDxHealth ADR's next earnings report will be released on 26 Feb 2026.

Is MDXH a Buy or Sell From a Technical Analyst Perspective?

Based on today's MDxHealth ADR moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has MDxHealth ADR Stock Split?

MDxHealth ADR has split 1 times. (See the MDXH stock split history page for full effective split date and price information.)

How Many Employees Does MDxHealth ADR Have?

MDxHealth ADR has 312 employees.

What is the current trading status of MDxHealth ADR (MDXH)?

As of 20 Jan 2026, MDxHealth ADR (MDXH) is trading at a price of 3.580, with a previous close of 3.840. The stock has fluctuated within a day range of 3.560 to 3.780, while its 52-week range spans from 1.350 to 5.330.

What Is MDxHealth ADR (MDXH) Price Target According to Analysts?

The average 12-month price target for MDxHealth ADR is USD7.040, with a high estimate of USD9 and a low estimate of USD4.2. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +96.65% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.